OPTN - Optinose Company Cash Funds

Graphic logo of optinose.com (OPTN)

OptiNose, Inc. (OPTN) is scaling the commercial reach of its nasal therapies by expanding the application of drugs for chronic sinusitis in the US. This chart on the GURU.Markets platform illustrates the cash on hand volume, where 0.07 captures the current value of the indicator. The company's revenues are based on the sale of proprietary drug delivery systems for the deep nasal cavities. Efficient component logistics and the diversification of plastic suppliers ensure high distribution margins.

Company Liquid Assets: OptiNose Inc (OPTN) for 07/04/2022 - 05/31/2025

Financial and market metric breakdowns for OptiNose (OPTN)

- stock value and consensus price forecast:
- market capitalization statistics:
Basic company analysis:OPTN OptiNose
Product sample of optinose.com

For OptiNose, Inc., which is competing for the nasal spray segment, the current cash balance serves as a key indicator of viability. This metric aggregates the total of the most liquid assets available for immediate deployment. It measures the business's ability to sustain operations without external borrowing. Amid aggressive marketing against generics, this reserve offsets declining margins. A reduction in funds signals a risk of capital depletion.

Who OptiNose, Inc. competes with

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Reserve Lipella Pharmaceuticals Inc|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance